Drug Database
Back to search

United States· US:67877-482_3176efce-402d-3398-e063-6294a90a2f27

telmisartan

A telmisartan product containing telmisartan, registered in United States by Ascend Laboratories, LLC. The same ATC class is registered in 17 of our 19 countries.

ATC C09CA07US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedtelmisartanATCC09CA07REGISTER NO.US:67877-482_3176efce…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about telmisartanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan is registered in 17 of 19 countries.

Countries holding a registration under ATC C09CA07 (telmisartan), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search telmisartan products by name

Telmisartan · ATC C09CA07

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of telmisartan costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.14 in France to $0.71 in Switzerland — a ×5.0 gap.

  • United States: $0.15 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Telmisartan · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.71
  • IT Italy$0.16
  • US United States$0.15 (acquisition cost)
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TELMISARTAN
Manufacturer
Ascend Laboratories, LLC
Country
United States (US)
ATC code
C09CA07
ATC class
Telmisartan
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    67877-482-05
  • ndc11
    67877-482-30
  • ndc11
    67877-482-90
  • ndc11
    6787748205
    500 TABLET in 1 BOTTLE (67877-482-05)
  • ndc11
    6787748230
    30 TABLET in 1 BOTTLE (67877-482-30)
  • ndc11
    6787748290
    90 TABLET in 1 BOTTLE (67877-482-90)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

334 interactions on record for telmisartan.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check telmisartan against other medicinesHow interaction checks work

Telmisartan · interactions on record

334 records

  • 7 severe
  • 121 moderate
  • 1 minor
  • 124 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Telmisartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Actelsar, Telmicard
  • Belgium · Telmisartan Eg, Telmisartan Teva
  • Bulgaria · Telsart, Tезео
  • Cyprus · Telmisartan Jubilant
  • Czechia · Telmisartan Egis, Telmisartan Ratiopharm
  • Germany · Telmisartan 1 A Pharma, Telmisartan Abz
  • Denmark · Telmisartan Medical Valley, Telmisartan Stada
  • Estonia · Telmisartaan Amarox, Telmisartan Ratiopharm
  • Spain · Telmark, Telmisartán Almus
  • Finland · Telmark, Telmisartan Amarox
  • France · Telmisartan Amarox, Telmisartan Arrow
  • United Kingdom (Northern Ireland) · Telmisartan Accord Healthcare, Telmisartan Amarox
  • Hungary · Tanydon, Telmisartan Egis
  • Ireland · Mirpresoc, Telmisartan Accord Healthcare Ireland
  • Iceland · Kinzalmono, Micardis
  • Italy · Telmisartan Almus, Telmisartan Alter
  • Liechtenstein · Kinzalmono, Micardis
  • Lithuania · Telmisartan Ingen Pharma, Telmisartan Inteli
  • Luxembourg · Telmisartan Eg, Telmisartan Micro Labs
  • Latvia · Telmisartan Ratiopharm, Tezeo
  • Netherlands · Telmisartan 1a Pharma, Telmisartan Amarox
  • Norway · Kinzalmono, Micardis
  • Poland · Actelsar, Polsart
  • Portugal · Diterpris, Mirpresoc
  • Romania · Tezeo
  • Sweden · Telmark, Telmisartan Amarox
  • Slovakia · Telmark, Telmisartan Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7f7f2c7-1fa4-4354-a0aa-482f6c2f7ca1
GET /v1/drugs/c7f7f2c7-1fa4-4354-a0aa-482f6c2f7ca1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20",
  "substance": "TELMISARTAN",
  "productndc": "67877-482",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA205150",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about telmisartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console